Hepatocellular Carcinoma; Targeted Therapy; Progression-free Survival
1 clinical trials · Condition
◉ Watch Hepatocellular Carcinoma; Targeted Therapy; Progression-free Survival
| Record | Firm | Date |
|---|---|---|
| Surufatinib Alone or Combined With Anti-PD-1 mAb in the Treatment of Advanced Hepatocellular Carcinoma (NCT05282433) | Zhongnan Hospital | 2022-04-16 |
Track Hepatocellular Carcinoma; Targeted Therapy; Progression-free Survival automatically
Every clearance here is in the API, with alerts when new ones post.